ESTRO PT 2018
Aim 1: Insight into Biologic Mechanisms Specific Aim 1: To determine the early changes in multiple biomarkers in patients undergoing RT, and how these changes differ in proton versus photon therapy. – Hypothesis: Early increases in circulating biomarkers will differ according to RT; photon therapy will result in a more adverse biomarker profile.
Biologic Alteration
Biomarker
Inflammation
GDF-15, hsCRP
Microvascular Dysfunction
PlGF
Oxidative Stress
MPO, PON, Aryl
Myocyte Injury
TnT
Myocyte Stress
NT-proBNP
Fibrosis
Galectin-3
Made with FlippingBook - Online Brochure Maker